The Neurosurgical Product Market is likely to mark stellar growth in the upcoming period. The current situation calls for conducive integrated healthcare models that do away with middlemen regarding offering various products and services. Drug manufacturers, hospital systems, PBMs (pharmacy benefit managers), wholesale distributors, hospital systems, medical insurers, and retail pharmacy outlets – are all into the integration of healthcare strategies. This would be how the healthcare vertical function in the upcoming period.

The global neurosurgical products market is characterized by the presence of top notch medical devices companies that manufacture specific neurosurgical products. Competitive rivalry among market players is intense due to moderate degree of product differentiation.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3303

The global neurosurgical products market is predicted to expand at a CAGR of 11.32% for the forecast period between 2017 and 2022, for the market’s valuation of US$4537.2 mn in 2017 to become US$7756.2 mn by the end of 2022.

Company Profiles:

• Integra LifeSciences Holdings Corporation
• KARL STORZ GmbH & Co. KG
• Medtronic plc
• Johnson & Johnson Services, Inc.
• Stryker Corporation
• Elekta AB
• Terumo Corporation
• Penumbra, Inc.
• B. Braun Melsungen AG
• Varian Medical Systems, Inc.
• Other

Get A Customized Scope To Match Your Need Ask An Expert –  sales@persistencemarketresearch.com

Embolization Products to Contribute Significant Revenue Through 2022

The global neurosurgical products market is segmented on the basis of condition, product type, procedure, and geography. By condition, hydrocephalus, aneurysms, arteriovenous malformations, and pituitary and intracranial tumors are the segments into which this market is divided. Of them, in absolute numbers, aneurysms stood as the leading segment in this market in 2017.

In terms of product type, the segments into which the neurosurgical products market is divided are embolization products, neurosurgical endoscopes, stereo tactic radiosurgery systems, aneurysm and AVM clips, shunts, and others. Among them, embolization products is likely to contribute the leading US$3,012.2 mn revenue to the overall market in 2022.

Depending upon procedure, the global neurosurgical products market is bifurcated into open surgery and minimally invasive surgery. Of the two, minimally invasive surgery segment hold prominence in the neurosurgical products market. The minimally invasive surgery segment is anticipated to rise at 11.98% CAGR over the forecast period between 2017 and 2022.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/3303

Rapidly Rising Geriatric Population to Make Asia Pacific Significant

On the basis of geography, the key segments into which the global neurosurgical products market is divided are North America, Europe, Asia Pacific, and Rest of the World. North America is currently the leading regional market for neurosurgical products; the region is predicted to hold on to its leading position in the years ahead. The high growth of North America neurosurgical products is mainly because of increasing healthcare expenditure in the region. According to 2014 statistics of the Organization for Economic Co-operation and Development, in 2012, healthcare spending in the U.S. were 16.9% of its GDP.

Apart from this, as per statistics of the World Health Organization, in 2000, almost 2.8 million individuals in the U.S. were inflicted by various forms of cancer such as brain cancer. In addition, as per statistics of Hindawi Publishing Corporation, almost 98,000 to 170,000 new brain metastases cases are reported every year in North America. Furthermore, initiatives undertaken by various governments to spread awareness about advanced neurosurgical products is also aiding the North America neurosurgical products market.

Europe stands as the second-leading regional market for neurosurgical products. This is mainly because of high healthcare expenditure across various countries such as France, Austria, Denmark, Germany, and the Netherlands. The rising number of neurosurgical procedures in the region is also a key factor behind the growth of Europe neurosurgical products market. For example, as per the National Health Scheme, neurosurgery is rising at 2%- 5% annually in England.

In Asia Pacific, growing population along with rapidly growing geriatric population are key growth drivers of the neurosurgical products market.

Read More Trending “PMR Exclusive Article”-

Intravitreal Injectables Market–Intravitreal Injectables Market Segmented By anti-VEGF, corticosteroids, antibiotics, antivirals and antifungals Drug Class with diabetic retinopathy, macular degeneration, endophthalmitis, retinal vein occlusions Indication

Dermatophytic Onychomycosis Therapeutics Market–Dermatophytic Onychomycosis Therapeutics Market Segmented By Tablets and Nail Paints Product in Oral, Topical Treatment in Hospitals, Clinics, Independent Pharmacies, Mail Order Pharmacies, Drug Stores

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com